Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 1,101,299 | 1,008,120 | 1,044,683 | 1,131,481 | 1,155,550 |
| Cost of Goods | 817,870 | 963,176 | 819,879 | 894,239 | 1,081,665 |
| Gross Profit | 283,429 | 44,944 | 224,804 | 237,242 | 73,885 |
| Operating Expenses | 214,897 | 221,408 | 209,804 | 223,620 | 245,373 |
| Operating Income | 68,532 | -176,464 | 15,000 | 13,622 | -171,488 |
| Interest Expense | 160 | 2,345 | 1,140 | 1,962 | 2,650 |
| Other Income | 12,224 | 5,433 | -2,432 | -2,206 | -38,734 |
| Pre-tax Income | 80,596 | -173,376 | 11,428 | 9,454 | -212,872 |
| Income Tax | 34,656 | 126,617 | -7,108 | 4,624 | -55,626 |
| Net Income Continuous | 56,069 | -86,076 | 42,121 | 10,073 | -153,688 |
| Net Income Discontinuous | 0 | -219,775 | 0 | 0 | 0 |
| Net Income | $56,069 | $-505,493 | $27,627 | $10,073 | $-153,688 |
| EPS Basic Total Ops | 0.53 | -1.31 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | 0.53 | -1.12 | N/A | N/A | N/A |
| EPS Basic Discontinuous Ops | N/A | -2.85 | N/A | N/A | N/A |
| EPS Diluted Total Ops | 0.42 | -1.31 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | 0.42 | -1.12 | N/A | N/A | N/A |
| EPS Diluted Discontinuous Ops | N/A | -2.85 | N/A | N/A | N/A |
| EBITDA(a) | $146,664 | $-94,982 | $100,332 | $107,273 | $-79,164 |